BSD Medical is Now Pyrexar Medical

The complete line of BSD Hyperthermia products are availble thru Pyrexar Medical

There have been a lot of firsts at the Maryland Proton Center. First Proton Center in the region; First center to offer both Hyperthermia + Protons at the same facility; and now they are experiencing an another First by treating their 2000th patient!

In their press release, the University states that "just three years after opening its doors, the Maryland Proton Treatment Center (MPTC) has reached a major milestone by treating its 2,000th patient. MPTC is the first proton treatment center to open in the District/Maryland/Virginia region. It is also the only treatment center in the world that offers both proton and thermal therapies in one facility". See the complete press release.

A key figure in the success of the thermal oncology department, Dr. Zeljko Vujaskovic, not only advocates for patients under his care; but continues to share his knowledge, research and advancements in thermal oncology as he travels the globe as a featured speaker at medical conferences. For Pyrexar Medical, it is a privilege to be associated with such an important group of professionals, researchers, and practitioners of thermal oncology.

Take a Virtual Tour of the BSD-2000

Take a virtual visit to the Thermal Oncology department at the University of Maryland and the BSD-2000 Deep Regional Hyperthermia System. [Note: Hold down the mouse key to move the camera, click to move around the room and use the mouse wheel to zoom

Last week we attended the CME accredited educational program offered by the University of Maryland, School of Thermal Oncology held at the Maryland Proton Center.

The course drew an international crowd including physicians from South Korea, Poland, and Japan, as well as prominent cancer centers here in the U.S. From the feedback we received, this was a five-star educational program, valuable to any member of a thermal oncology team.  Topics covered all aspects of practice management, patient treatment, physics, and workflow. Practice managers shared how adding thermal oncology to their services increased overall service revenue by over 19%.  This is important for centers that would like to add hyperthermia systems but require cost justification to receive purchase approval.

Based on the higher than expected turnout and the response from the participants, we expect this to be offered again in 2020.

Pyrexar Medical continues to support educational outreach from organizations like the University of Maryland, Society of Thermal Medicine, European Society for Hyperthermic Oncology and similar institutions who strive to move forward hyperthermia research in the treatment of cancer. The CME course outline can be found here.

Pyrexar Medical will be an exhibiting sponsor of the PTCOG-NA (Particle Therapy Co-Operative Group - North America) in Miami, Florida, October 14-16. This is our first participation in this annual event. Our interest in proton therapy was peaked after reading a 2014 article published in the International Journal of Hyperthermia by Prof. Dr. Niloy Datta exploring proton therapy and hyperthermia.

pictureicon bragg peak proton therapy scripps health

Since then, Pyrexar placed a BSD-2000 Deep Regional Hyperthermia System at the University of Maryland Proton Center.  This is the first installation in the world to offer both a proton therapy system and hyperthermia system under the same roof.  This installation, along with further clinical study, will move us closer to understanding the relationship of protons combined with focused heating.

For more information on attending the upcoming PTCOG-NA conference, follow the link.

In the last few weeks, Pyrexar products were being presented at conferences in Warsaw, Poland; Miami, Florida; Barcelona, Spain; and Münster, Germany.  So thankful for our great partners educating oncologists and physicists, all over the world, to the benefits of hyperthermia in the treatment of cancer. We wanted to share a few images of these events with you.

ESHO - Warsaw, Poland

Pyrexar ESHO Award

2019 Pyrexar ESHO Award

The ESHO-Pyrexar Award, presented by Dr. Sennewald Medizintechnik Gmbh, is awarded annually for outstanding contributions to hyperthermic oncology, education, and scientific achievement. This year's recipient is Prof. Dr. med. Lars Lindner.  Dr. Lindner is a respected thermal oncologist and researcher, well known for the landmark study "Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma" published in Jama earlier this year.  We congratulate him and his team for their contributions to thermal medicine. More information about ESHO (European Society for Hyperthermic Oncology) can be found here.


SEOR - Barcelona, Spain

Pyrexar at SEOR 2019

This was our first time at the SEOR (Spanish Society of Radiation Oncology) in Spain, represented by our distributor Magna Medic Systems based in Málaga, Spain.  The organization has been making tremendous strides in the introduction of hyperthermia to oncologists in the region.


DEGRO - Münster, Germany

Pyrexar represented at the DEGRO 2019

Our distribution partner, Dr. Sennewald Medizintechnik Gmb, was a silver sponsor at DEGRO (German Society of Radiation Oncology) and held a lunch symposium focused on reimbursement issues in Germany.


ABS - Miami Florida

Pyrexar Medical exhibiting at the ABS 2019

This was Pyrexar's first engagement at the ABS (American Brachytherapy Society).  Our goal was to demonstrate that adding hyperthermia as an adjunct to brachytherapy boosted the effectiveness of this radiotherapy treatment without interrupting workflow. It was an excellent show and we will be back next year.